Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
Clinical trial NCT04307186 · COMPLETED
Trial details
- NCT number
- NCT04307186
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2022-09-05
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.